Skip to main content
TipRanks
Go Ultimate75% OFF

AIM ImmunoTech (0A4Y) Stock Statistics & Valuation Metrics

1 Followers

Total Valuation

AIM ImmunoTech has a market cap or net worth of $5.23M. The enterprise value is -$1.18M.

Market Cap
$5.23M
Enterprise Value
-$1.18M

Share Statistics

AIM ImmunoTech has 39,919,846 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
39,919,846
Owned by Insiders
0.99%
Owned by Institutions
0.13%

Financial Efficiency

AIM ImmunoTech’s return on equity (ROE) is 1.43 and return on invested capital (ROIC) is -313.55%.

Return on Equity (ROE)
1.43
Return on Assets (ROA)
-2.41
Return on Invested Capital (ROIC)
-313.55%
Return on Capital Employed (ROCE)
23.81
Revenue Per Employee
4,631.579
Profits Per Employee
-734.63K
Employee Count
19
Asset Turnover
0.02
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of AIM ImmunoTech is -0.05. AIM ImmunoTech’s PEG ratio is -0.00.

PE Ratio
-0.05
PS Ratio
57.42
PB Ratio
0.60
Price to FCF
-2.51
Price to Operating Cash Flow
-0.87
PEG Ratio
-0.00

Income Statement

In the last 12 months, AIM ImmunoTech had revenue of 88.00K and earned -13.96M in profits. Earnings per share was -8.62.

Revenue
88.00K
Gross Profit
-250.00K
Operating Income
-10.53M
Pretax Income
-13.96M
Net Income
-13.96M
EBITDA
-12.94M
Earnings Per Share (EPS)
-8.62

Cash Flow

In the last 12 months, operating cash flow was -4.92M and capital expenditures 2.84M, giving a free cash flow of -2.08M billion.

Operating Cash Flow
-4.92M
Free Cash Flow
-2.08M
Free Cash Flow per Share
-0.06

Dividends & Yields

AIM ImmunoTech pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-39.79%
Earnings Yield
-331.92%

Stock Price Statistics

Beta
1.12
52-Week Price Change
-90.75%
50-Day Moving Average
0.18
200-Day Moving Average
0.41
Relative Strength Index (RSI)
37.95
Average Volume (3m)
92.63K

Important Dates

AIM ImmunoTech upcoming earnings date is Aug 17, 2027, TBA (Not Confirmed).

Last Earnings Date
Aug 10, 2026
Next Earnings Date
Aug 17, 2027
Ex-Dividend Date
―

Financial Position

AIM ImmunoTech as a current ratio of 0.53, with Debt / Equity ratio of -50.05%

Current Ratio
0.53
Quick Ratio
0.53
Debt to Market Cap
2.58
Net Debt to EBITDA
-0.31
Interest Coverage Ratio
-12.96

Taxes

In the past 12 months, AIM ImmunoTech has paid 0 in taxes.

Income Tax
0
Effective Tax Rate
0.00

Enterprise Valuation

AIM ImmunoTech EV to EBITDA ratio is 0.12, with an EV/FCF ratio of 0.68.

EV to Sales
-15.63
EV to EBITDA
0.12
EV to Free Cash Flow
0.68
EV to Operating Cash Flow
0.29

Balance Sheet

AIM ImmunoTech has $6.95M in cash and marketable securities with $235.00K in debt, giving a net cash position of $6.71M billion.

Cash & Marketable Securities
$6.95M
Total Debt
$235.00K
Net Cash
$6.71M
Net Cash Per Share
$0.17
Tangible Book Value Per Share
$0.16

Margins

Gross margin is -8.79%, with operating margin of -12800.00%, and net profit margin of -15526.37%.

Gross Margin
-8.79%
Operating Margin
-12800.00%
Pretax Margin
-15526.37%
Net Profit Margin
-15526.37%
EBITDA Margin
-13170.33%
EBIT Margin
-14153.85%

Analyst Forecast

The average price target for AIM ImmunoTech is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
-18.75%
EPS Growth Forecast
88.22%